Liron Spitzer

ORCID: 0000-0003-4311-2152
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Regulation of Appetite and Obesity
  • Pneumocystis jirovecii pneumonia detection and treatment
  • SARS-CoV-2 and COVID-19 Research
  • Syphilis Diagnosis and Treatment
  • Eating Disorders and Behaviors
  • Sarcoidosis and Beryllium Toxicity Research
  • Urticaria and Related Conditions
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • COVID-19 epidemiological studies
  • Autoimmune Bullous Skin Diseases
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Body Image and Dysmorphia Studies
  • Biochemical Analysis and Sensing Techniques
  • Vaccine Coverage and Hesitancy

Tel Aviv Sourasky Medical Center
2018-2022

Tel Aviv University
2018-2022

<h3>Importance</h3> Administration of a BNT162b2 booster dose (Pfizer-BioNTech) to fully vaccinated individuals aged 60 years and older was significantly associated with lower risk SARS-CoV-2 infection severe illness. Data are lacking on the effectiveness doses for younger health care workers. <h3>Objective</h3> To estimate association infections among workers who were previously 2-dose series BNT162b2. <h3>Design, Setting, Participants</h3> This prospective cohort study conducted at...

10.1001/jama.2021.23641 article EN JAMA 2022-01-10

Abstract Sexual dimorphisms are responsible for profound metabolic differences in health and behavior. Whether males females react differently to environmental cues, such as solar ultraviolet (UV) exposure, is unknown. Here we show that exposure induces food-seeking behavior, food intake, behavior intake men, but not women, through epidemiological evidence of approximately 3,000 individuals throughout the year. In mice, UVB leads increased weight gain, with a sexual dimorphism towards males....

10.1038/s42255-022-00587-9 article EN cc-by Nature Metabolism 2022-07-11

&lt;b&gt;&lt;i&gt;Introduction:&lt;/i&gt;&lt;/b&gt; In a randomized prospective trial, adjuvant rituximab was more efficacious than corticosteroids alone in the treatment of pemphigus; however, real-life data are limited. Rituximab for pemphigus has only recently been introduced to Israeli health basket. Previously, patients received if they paid out pocket or through private insurance, separating into 2 groups, mostly based on economic capability....

10.1159/000508788 article EN Dermatology 2020-08-05
Coming Soon ...